Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical heparin for pigmented purpuric dermatosis
IRCT20250307064969N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in capillaritis (PPD) comparing Topical heparin gel with Placebo gel (2 arms). Primary endpoints: Improvement of skin lesions, Patient satisfaction and 2 more. Started Jun 2025; status: completed.
02
Drugs
heparin
03
Conditions
capillaritis (PPD)
Beyond the preview
Go deeper on IRCT20250307064969N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250307064969N1.